Leo Widler

1.2k total citations
21 papers, 962 citations indexed

About

Leo Widler is a scholar working on Organic Chemistry, Oncology and Molecular Biology. According to data from OpenAlex, Leo Widler has authored 21 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 7 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Leo Widler's work include Bone health and treatments (7 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Parathyroid Disorders and Treatments (3 papers). Leo Widler is often cited by papers focused on Bone health and treatments (7 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Parathyroid Disorders and Treatments (3 papers). Leo Widler collaborates with scholars based in Switzerland and United States. Leo Widler's co-authors include Dieter Seebàch, Jonathan R. Green, Knut A. Jaeggi, Eva Altmann, Martin Missbach, Markus Glatt, Mira Šuša, Jonathan A. Green, Klaus Müller and Reto Cortesi and has published in prestigious journals such as Journal of Medicinal Chemistry, Cell Reports and Bone.

In The Last Decade

Leo Widler

21 papers receiving 913 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leo Widler Switzerland 16 409 363 330 124 107 21 962
Knut A. Jaeggi Switzerland 13 137 0.3× 306 0.8× 578 1.8× 250 2.0× 313 2.9× 20 1.0k
Irina Alho Portugal 18 112 0.3× 362 1.0× 411 1.2× 32 0.3× 60 0.6× 41 852
Neil G. Almstead United States 20 628 1.5× 669 1.8× 349 1.1× 16 0.1× 23 0.2× 44 1.6k
Javier Rojas Spain 9 221 0.5× 222 0.6× 212 0.6× 125 1.0× 24 0.2× 13 599
Mukund M. Mehrotra United States 15 314 0.8× 297 0.8× 188 0.6× 10 0.1× 34 0.3× 31 910
Norbert Schmees Germany 11 288 0.7× 281 0.8× 112 0.3× 6 0.0× 19 0.2× 19 870
Stefan Jaroch Germany 14 244 0.6× 228 0.6× 105 0.3× 6 0.0× 21 0.2× 24 843
Kazuya Takenouchi Japan 17 242 0.6× 175 0.5× 57 0.2× 5 0.0× 33 0.3× 52 729
Christopher J. O’Donnell United States 27 799 2.0× 835 2.3× 483 1.5× 3 0.0× 510 4.8× 54 2.1k
Peppi Prasit United States 21 242 0.6× 592 1.6× 126 0.4× 13 0.1× 11 0.1× 44 1.2k

Countries citing papers authored by Leo Widler

Since Specialization
Citations

This map shows the geographic impact of Leo Widler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leo Widler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leo Widler more than expected).

Fields of papers citing papers by Leo Widler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leo Widler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leo Widler. The network helps show where Leo Widler may publish in the future.

Co-authorship network of co-authors of Leo Widler

This figure shows the co-authorship network connecting the top 25 collaborators of Leo Widler. A scholar is included among the top collaborators of Leo Widler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leo Widler. Leo Widler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Liqing, Jascha Parkington, Samuel M. Cadena, et al.. (2019). HDAC4 Controls Muscle Homeostasis through Deacetylation of Myosin Heavy Chain, PGC-1α, and Hsc70. Cell Reports. 29(3). 749–763.e12. 67 indexed citations
2.
John, Markus R., Juergen Loeffler, Rossella Belleli, et al.. (2014). AXT914 a novel, orally-active parathyroid hormone-releasing drug in two early studies of healthy volunteers and postmenopausal women. Bone. 64. 204–210. 32 indexed citations
3.
Widler, Leo, Wolfgang Jahnke, & Jonathan R. Green. (2012). The Chemistry of Bisphosphonates: From Antiscaling Agents to Clinical Therapeutics. Anti-Cancer Agents in Medicinal Chemistry. 12(2). 95–101. 20 indexed citations
4.
John, Markus R., Leo Widler, R. Gamse, et al.. (2011). ATF936, a novel oral calcilytic, increases bone mineral density in rats and transiently releases parathyroid hormone in humans. Bone. 49(2). 233–241. 32 indexed citations
5.
Widler, Leo. (2011). Calcilytics: Antagonists of the Calcium-Sensing Receptor for the Treatment of Osteoporosis. Future Medicinal Chemistry. 3(5). 535–547. 34 indexed citations
6.
Gerspacher, Marc, Eva Altmann, Thomas Buhl, et al.. (2010). Penta-substituted benzimidazoles as potent antagonists of the calcium-sensing receptor (CaSR-antagonists). Bioorganic & Medicinal Chemistry Letters. 20(17). 5161–5164. 9 indexed citations
7.
Widler, Leo, Knut A. Jaeggi, Markus Glatt, et al.. (2002). Highly Potent Geminal Bisphosphonates. From Pamidronate Disodium (Aredia) to Zoledronic Acid (Zometa). Journal of Medicinal Chemistry. 45(17). 3721–3738. 266 indexed citations
8.
Altmann, Eva, Leo Widler, & Martin Missbach. (2002). N7-Substituted-5-aryl-pyrrolo[2,3-d]pyrimidines Represent a Versatile Class of Potent Inhibitors of the Tyrosine Kinase c-Src. Mini-Reviews in Medicinal Chemistry. 2(3). 201–208. 11 indexed citations
9.
Altmann, Eva, Martin Missbach, Jonathan A. Green, et al.. (2001). 7-Pyrrolidinyl- and 7-piperidinyl-5-aryl-pyrrolo[2,3-d]pyrimidines—potent inhibitors of the tyrosine kinase c-Src. Bioorganic & Medicinal Chemistry Letters. 11(6). 853–856. 34 indexed citations
10.
Widler, Leo, Jonathan A. Green, Martin Missbach, Mira Šuša, & Eva Altmann. (2001). 7-Alkyl- and 7-Cycloalkyl-5-aryl-pyrrolo[2,3-d]pyrimidines—potent inhibitors of the tyrosine kinase c-Src. Bioorganic & Medicinal Chemistry Letters. 11(6). 849–852. 43 indexed citations
11.
Missbach, Martin, Eva Altmann, Leo Widler, et al.. (2000). Substituted 5,7-diphenyl-pyrrolo[2,3 d ]pyrimidines: potent inhibitors of the tyrosine kinase c-Src. Bioorganic & Medicinal Chemistry Letters. 10(9). 945–949. 40 indexed citations
12.
Widler, Leo, Knut A. Jaeggi, & Jonathan R. Green. (1999). Amino-Substituted GEM-Bisphosphonates. Phosphorus, sulfur, and silicon and the related elements. 144(1). 5–8. 14 indexed citations
13.
Green, Jonathan R., et al.. (1997). Renal Tolerability Profile of Novel, Potent Bisphosphonates in Two Short‐Term Rat Models. Pharmacology & Toxicology. 80(5). 225–230. 77 indexed citations
14.
Geiger, Thomas, et al.. (1994). CGP 47969A: effect on collagen induced arthritis in DBA/1 mice.. PubMed. 21(11). 1992–7. 15 indexed citations
15.
Prager, Bernhard, et al.. (1986). Stereoselective Reduction of δ‐Hydroxy‐β‐ketoesters. Helvetica Chimica Acta. 69(4). 803–805. 40 indexed citations
16.
Seebàch, Dieter, Beat Weidmann, & Leo Widler. (1983). ChemInform Abstract: TITANIUM AND ZIRCONIUM DERIVATIVES IN ORGANIC SYNTHESIS. A REVIEW WITH PROCEDURES. Chemischer Informationsdienst. 14(43). 2 indexed citations
17.
Seebàch, Dieter, et al.. (1983). Some recent advances in the use of titanium reagents for organic synthesis. Pure and Applied Chemistry. 55(11). 1807–1822. 82 indexed citations
18.
Widler, Leo, et al.. (1982). Diastereoselektive Synthese von β‐Methyl‐homoallylalkoholen durchlk‐Addition von (2‐Butenyl)triphenoxytitan an Aldehyde. Helvetica Chimica Acta. 65(3). 1085–1089. 34 indexed citations
19.
Seebàch, Dieter & Leo Widler. (1982). A case of highly diastereoselective addition to unsymmetrical ketones: lk‐addition of (2‐alkenyl)triphenoxytitanium derivatives. Helvetica Chimica Acta. 65(7). 1972–1981. 41 indexed citations
20.
Weidmann, Beat, Leo Widler, Alan G. Olivero, Christopher D. Maycock, & Dieter Seebàch. (1981). Selectivities in the Reactions of Alkyl‐, Aryl‐ and Heterosubstituted Organotitanium Compounds Preliminary Communication. Helvetica Chimica Acta. 64(1). 357–361. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026